Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-10-28 to 2024-11-19
Current total value of award: $25924.44
Description: 4566289114!HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML